Purpose: Magnetic resonance (MR)-guided SABR was performed for patients with lung tumors in whom treatment delivery was challenging owing to tumor location, motion, or pulmonary comorbidity. Because stereotactic MR-guided adaptive radiation therapy (SMART) is a novel approach, we studied clinical outcomes in these high-risk lung tumors. Methods and Materials: Fifty consecutive patients (54 lung tumors) underwent SMART between 2016 and 2018 for either a primary lung cancer (29 patients) or for lung metastases (21 patients). Eligible patients had risk factors that could predispose them to toxicity, including a central tumor location (n = 30), previous thoracic radiation therapy (n = 17), and interstitial lung disease (n = 7). A daily 17-secon...
PURPOSE: To investigate, in the setting of stereotactic ablative radiation therapy (SABR) for early-...
Introduction: Stereotactic body radiotherapy (SBRT) reported excellent outcomes and a good tolerabil...
Objective: To examine disease control and survival after stereotactic body radiotherapy (SBRT) for m...
BACKGROUND AND PURPOSE: We studied the benefits of using stereotactic MR-guided adaptive radiation t...
Purpose: To investigate the clinical outcomes of stage I and IIA non-small cell lung cancer (NSCLC) ...
Introduction:The use of stereotactic ablative radiotherapy (SABR) in centrally located early-stage l...
Purpose: Changes in position or size of target volumes have been observed during radiotherapy for lu...
Stereotactic body radiotherapy (SBRT) uses hypofractionated and more precise irradiation methods, an...
The treatment of central and ultracentral lung tumors with radiotherapy remains an ongoing clinical ...
PURPOSE: The impact of stereotactic body radiotherapy (SBRT) on 3-year progression-free survival of ...
Backgrounds: In addition to its curative use for early stage lung cancer, stereotactic ablative radi...
Background: To clarify the clinical outcomes of two dose schedule of stereotactic body radiotherapy ...
PURPOSE: To investigate, in the setting of stereotactic ablative radiation therapy (SABR) for early-...
PURPOSE: Stereotactic radiosurgery (SRS) represents a treatment option for patients with brain metas...
Introduction:The use of stereotactic ablative radiotherapy (SABR) in centrally located early-stage l...
PURPOSE: To investigate, in the setting of stereotactic ablative radiation therapy (SABR) for early-...
Introduction: Stereotactic body radiotherapy (SBRT) reported excellent outcomes and a good tolerabil...
Objective: To examine disease control and survival after stereotactic body radiotherapy (SBRT) for m...
BACKGROUND AND PURPOSE: We studied the benefits of using stereotactic MR-guided adaptive radiation t...
Purpose: To investigate the clinical outcomes of stage I and IIA non-small cell lung cancer (NSCLC) ...
Introduction:The use of stereotactic ablative radiotherapy (SABR) in centrally located early-stage l...
Purpose: Changes in position or size of target volumes have been observed during radiotherapy for lu...
Stereotactic body radiotherapy (SBRT) uses hypofractionated and more precise irradiation methods, an...
The treatment of central and ultracentral lung tumors with radiotherapy remains an ongoing clinical ...
PURPOSE: The impact of stereotactic body radiotherapy (SBRT) on 3-year progression-free survival of ...
Backgrounds: In addition to its curative use for early stage lung cancer, stereotactic ablative radi...
Background: To clarify the clinical outcomes of two dose schedule of stereotactic body radiotherapy ...
PURPOSE: To investigate, in the setting of stereotactic ablative radiation therapy (SABR) for early-...
PURPOSE: Stereotactic radiosurgery (SRS) represents a treatment option for patients with brain metas...
Introduction:The use of stereotactic ablative radiotherapy (SABR) in centrally located early-stage l...
PURPOSE: To investigate, in the setting of stereotactic ablative radiation therapy (SABR) for early-...
Introduction: Stereotactic body radiotherapy (SBRT) reported excellent outcomes and a good tolerabil...
Objective: To examine disease control and survival after stereotactic body radiotherapy (SBRT) for m...